Internationally Recognized Addiction Treatment Specialist Dr. Michael Frost Joins Wayspring’s C-Suite, Along with Several Other Experienced Senior Leaders
(NASHVILLE, Tennessee – January 13, 2022) – Wayspring, a leading risk-based provider of high-touch care coordination and treatment services for those with substance use disorder (SUD), has added Dr. Michael Frost as the company’s Chief Medical Officer.
“Over the past several years, Wayspring has been working to bring high-quality, evidence-based medicine to the many individuals with SUD that have been underserved by our healthcare system,” said Frazer Buntin, COO of Wayspring. “Addiction treatment is one of the most complex and rapidly evolving sectors in healthcare. Adding Dr. Frost, an internationally-recognized expert in the field of addiction, to the team will help us to continue to be on the forefront of innovation.”
Frost brings more than nineteen years of addiction treatment expertise to Wayspring. He is a fellow of The American College of Physicians and a Distinguished Fellow of The American Society of Addiction Medicine as well as a member of the Canadian Society of Addiction Medicine. He has served as a medical director for several addiction treatment facilities. Dr. Frost is also heavily involved in new treatment development, clinical research and consults with numerous companies regarding clinical development and healthcare policy. He is widely published, and his work has been presented across the United States, Canada, and Europe.
“I am thrilled to join Wayspring’s leadership team at this critical moment as we work to address the addiction crisis the country is currently facing” said Frost. “Wayspring has the team and services necessary to make a real impact on how substance use disorders are addressed and it is exciting to have a role in helping to advance the field.”
As Chief Medical Officer, Frost will oversee medical and behavioral health provider services as part of Wayspring’s SUD Home model, provide guidance and development of treatment approaches for members with SUD, as well support existing market clinical operations.
In addition to Frost, the company has recently added several experienced senior leaders including Courtney Henchon (Senior Vice President of Clinical Operations), Judy Slagle (Senior Vice President of Health Services), Kate Johnson (Vice President of Solution Improvement), Jennifer Johnson (Vice President of Clinical Operations), and Tanya Deane (Vice President of Human Resources).
Frost, along with the other new members of Wayspring’s leadership team, are joining the company during a period of rapid growth. Over the past 12 months, Wayspring has deployed its value-based SUD Home model with several health plan partners. Today, Wayspring operates in seven states. The company raised $75 million in 2021 from leading healthcare investors to support the expansion of the model.
Wayspring is a value-based care entity exclusively focused on substance use disorder. The company leverages data analytics to outreach to the highest-risk individuals and deliver high-touch, community-based peer support, addiction treatment, behavioral health, and primary care services. Wayspring also partners with existing provider networks to refer members to high-quality treatment, facilitate care transitions, and improve adherence to evidence-based medicine. For more information, visit www.wayspring.com.